Trillium Therapeutics financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2004 2023
Rev. Revenue
C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.12M C$0.15M C$0.00M C$0.00M C$0.00M
GM % Gross Margin %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
C$0.00 C$0.00
Div. Dividends
C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0.2m 0.2m 0.25m 0.44m 0.51m 0.56m 0.62m 0.62m 4.06m 4.28m 7.35m 7.85m 13.15m 14.69m 28.04m 85.83m 103.03m 0m 0m
OCF Operating Cash Flow
C$-2.15M C$-4.44M C$-4.75M C$-4.65M C$-4.09M C$-3.89M C$-1.89M C$-1.32M C$-2.48M C$-7.45M C$-18.30M C$-22.85M C$-27.04M C$-30.46M C$-24.75M C$-22.73M C$0.00M C$-0.82M C$0.00M
FCF Free Cash Flow
C$-2.22M C$-4.45M C$-4.79M C$-4.67M C$0.00M C$-3.91M C$0.00M C$0.00M C$-2.51M C$-7.62M C$-19.05M C$-25.82M C$-27.51M C$-39.38M C$-25.07M C$-28.26M C$0.00M C$-0.89M C$0.00M
FCFS Free Cash Flow Per Share
C$-12.63 C$-24.85 C$-20.07 C$-12.69 C$-8.98 C$-7.49 C$-3.11 C$-2.12 C$-1.85 C$-1.81 C$-2.87 C$-3.30 C$-2.82 C$-2.20 C$-0.99 C$-0.27 C$0.00 C$-34.26 C$0.00